Starting in 2027, hospitals with a high rate of contested billings will face significantly more audits, up to and including an unlimited audit quota. For Calliora, this change is more than just a favorable market environment. It addresses the exact problem the company, founded in 2023, is tackling with its AI platform: identifying errors and missing information before a hospital bill is sent to health insurance providers. At the same time, the software aims to highlight where information is lost or processes fail to align within hospital operations.
This regulatory pressure arrives at a time when many German hospitals are already under financial strain. According to the Hospital Barometer from the German Hospital Institute (DKI), roughly two-thirds of hospitals posted losses in 2024.
From 2027, Hospitals Face Audit Quotas of Up to 100 Percent
In July 2026, the Bundestag passed the Statutory Health Insurance Contribution Rate Stabilization Act (GKV-Beitragssatzstabilisierungsgesetz). It significantly tightens the rules governing audits of hospital billings by health insurance providers.
If the share of uncontested billings is between 50 and 65 percent, an audit quota of 40 percent will apply in the future. If the share of uncontested bills falls below 50 percent, unlimited audits are possible according to the Federal Ministry of Health. Mathematically, this means: If more than half of audited billings are contested, every single one of a hospital’s invoices could be audited in extreme cases.
For hospitals, this increases the economic value of accurate documentation and billing. That is because errors do not necessarily arise only when the invoice is created. Medical and nursing documentation, coding, medical controlling, and billing are interconnected and often spread across different systems and responsibilities.
AI Platform Connects Documentation, Coding, and Medical Controlling
The software from Munich-based startup Calliora is not intended to replace existing hospital applications, but rather to sit on top of them as an additional layer. It consolidates information from clinical documentation, hospital information systems, coding, and audit procedures.
If, for example, a diagnosis has been documented but not yet correctly coded, or if proof relevant for a later audit is missing, the platform is designed to alert the responsible team before the invoice is sent.
Its scope of application extends beyond actual invoicing. The platform currently covers areas including coding, case review, MD management, and controlling. Looking ahead, it is intended to guide a treatment case all the way from admission to reimbursement.
Final decisions remain with medical coders and medical controllers. Only what is documented in the patient file is billed. According to Calliora, sensitive data is processed in Germany in compliance with GDPR.
Co-founder and CEO Frederik Träuble compares the function to an assistant in the operating room:
“Calliora does that for medical coding and medical controlling. It provides the missing diagnosis or missing documentation precisely when it’s needed. It doesn’t make the incision. That remains the specialists’ job.”
Calliora reports over 50 percent less effort per case
According to Calliora, the platform is already in use in private, public, and church-run hospitals across five German states. It has reportedly reduced the workload per case by more than half.
According to Calliora, hospital teams close more than 90 percent of the gaps identified by the software before billing. This also helps reduce the dispute rate in audits conducted by the German Medical Service (Medizinischer Dienst).
The figures are provided by the company; publicly accessible independent evaluations of results from individual hospitals are not yet available.
This also raises one of the key questions for the next phase of growth: Can the efficiency gains reported so far be replicated when rolling out across a larger number of diverse hospitals?
BHI and Redalpine Lead Pre-Seed Round
Calliora has now raised 5.3 million euros (6 million dollars) for its further expansion. The pre-seed round is led by Bertelsmann Healthcare Investments and the Swiss VC Redalpine.
In addition, business angels from hospital management and AI are participating. These include former Asklepios and Mediclin CEO Ulrich Wandschneider, Deloitte manager Sara Siegel, Peter Sarlin, and AI researcher Frank Hutter.
BHI also sees parallels with the US healthcare market. Maximilian Boner, Europe Lead at BHI, says:
“In the US, error-free real-time billing is becoming established as the key to greater cost-effectiveness in hospitals. Calliora is now bringing this principle to Europe and tackling the issue right at the source, instead of correcting errors after the fact.”
The fresh capital is primarily intended to flow into AI, engineering, and product development. In addition, Calliora aims to expand its platform across further stages of patient case progression.
